Skip to main content
SpringerLink
Log in

Pharmacokinetics of clonidine in the rat and cat

  • Published:
Journal of Pharmacokinetics and Biopharmaceutics Aims and scope Submit manuscript

Abstract

To investigate the pharmacokinetic behavior of clonidine, rats were given clonidine intravenously at 125, 250, and 500μg/kg and blood clonidine concentrations were followed for 6 hr. The disposition of clonidine in two brain regions was studied in rats after an i. v. dose of 500 μg/kg. The liver clearance in rats was investigated by liver perfusion techniques. The results obtained indicate that the disposition characteristics of clonidine can be described by a two-compartment open model in both rats and cats. The penetration of clonidine into tissues is rapid, and brain levels in rats were about 1.7 times higher than blood levels. Brain tissues were found to be an indistinguisible part of the central (blood) compartment. Dose-dependent pharmacokinetic behavior was found for clonidine in rats at the doses used. This was demonstrated by a decrease of both the rate constant of distribution to the peripheral compartment and the overall elimination rate constant from the body, with increase in dose. As a consequence, the volume of distribution and the clearance both decreased with increasing dose. Possible explanations for the dose-dependent behavior of clonidine are discussed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. W. Hoefke and W. Kobinger. Pharmakologische Wirkungen des 2-(2,6-Dichlorphenyl-amino)-2-imidazolinhydrochlorids, einer neuen, antihypertensiven Substanz.Arzneim.-Forsch. 16:1038–1050 (1966).

    CAS  Google Scholar 

  2. W. Kobinger and A. Walland. Investigations into the mechanism of the hypotensive effect of 2-(2,6-dichlorphenylamino)-2-imidazoline-HCl.Eur. J. Pharmacol. 2:155–162 (1967).

    Article  CAS  PubMed  Google Scholar 

  3. K. D. Bock, V. Heimsoth, P. Merguet, and J. Schönermark. Klinische und klinisch-experimentelle Untersuchungen mit einer neuen blutdrucksenkenden Substanz: Dichlorphenylaminoimidazolin.Deutsch. Med. Wochenschr. 91:1761–1770 (1966).

    Article  CAS  Google Scholar 

  4. W. Kobinger. In O. Onesti, K. E. Kim, and I. J. Meyer (eds.),Hypertension Mechanisms and Managements, Grune and Stratton, New York, 1973, pp. 369–382.

    Google Scholar 

  5. R. W. Sattler and P. A. van Zwieten. Acute hypotensive action of 2-(2,6-dichlorophenyl-amino)-2-imidazoline hydrochloride (ST 155) after infusion into the cat's vertebral artery.Eur. J. Pharmacol. 2:9–13 (1967).

    Article  CAS  PubMed  Google Scholar 

  6. H. Schmitt, H. Schmitt, J. R. Boissier, J. F. Giudicelli, and J. Fichelle. Cardiovascular effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST 155).Eur. J. Pharmacol. 2:340–346 (1968).

    Article  CAS  PubMed  Google Scholar 

  7. P. Bolme and K. Fuxe. Pharmacological studies on the hypotensive effects of clonidine.Eur. J. Pharmacol. 13:168–174 (1971).

    Article  CAS  PubMed  Google Scholar 

  8. G. Haeusler. Further similarities between the action of clonidine and a central activation of the depressor baroreceptor reflex.Naunyn-Schmiedeberg's Arch. Pharmacol. 285:1–14 (1974).

    Article  CAS  Google Scholar 

  9. H. Brüner and K. E. Klein. In L. Heilmeyer, H. J. Holtmeier, and E. F. Pfeiffer (eds.),Hochdruck-therapie, G. Thieme, Stuttgart, 1968, pp. 180–184.

    Google Scholar 

  10. B. Delbarre and H. Schmitt. Sedative effects of α-sympathomimetic drugs and their antagonism by adrenergic and cholinergic blocking drugs.Eur. J. Pharmacol. 13:356–363 (1971).

    Article  CAS  PubMed  Google Scholar 

  11. L. Paalzow. Analgesia produced by clonidine in mice and rats.J. Pharm. Pharmacol. 26:361–363 (1974).

    Article  CAS  PubMed  Google Scholar 

  12. H. Schmitt, J.-C. Le Douraec, and N. Petillot. Antinociceptive effects of someα-sympathomimetic agents.Neuropharmacology 13:289–294 (1974).

    Article  CAS  PubMed  Google Scholar 

  13. G. Paalzow and L. Paalzow. Clonidine antinociceptive activity: Effects of drugs influencing central monoaminergic and cholinergic mechanisms in the rat.Naunyn-Schmiedeberg's Arch. Pharmacol. 292:119–126 (1976).

    Article  CAS  Google Scholar 

  14. A. K. Cho and S. H. Curry. The physiological disposition of 2-(2,6-dichloroanilino)-2-imidazoline (ST 155).Biochem. Pharmacol. 18:511–520 (1969).

    Article  CAS  PubMed  Google Scholar 

  15. D. Rehbinder. In A. Zanchetti and M. Enrico (eds.),Ipertensione Arteriosa, Boehringer Ingelheim, Firenze, 1973, pp. 3–22.

    Google Scholar 

  16. C. T. Dollery, D. S. Davies, G. H. Draffan, H. J. Dargie, C. R. Dean, J. L. Reid, R. A. Clare, and S. Murray. Clinical pharmacology and pharmacokinetics of clonidine.Clin. Pharmacol. Ther. 19:11–17 (1976).

    CAS  PubMed  Google Scholar 

  17. D. S. Davies, L. M. H. Wing, J. L. Reid, E. Neill, P. Tippett, and C. T. Dollery. Pharmacokinetics and concentration-effect relationships of intravenous and oral clonidine.Clin. Pharmacol. Ther. 21:593–601 (1977).

    CAS  PubMed  Google Scholar 

  18. P. O. Edlund and L. K. Paalzow. Quantitative gas-liquid chromatographic determination of clonidine in plasma.Acta Pharmacol. Toxicol. 40:145–152 (1977).

    Article  CAS  Google Scholar 

  19. R. A. Upton. Simple and reliable method for serial sampling of blood from rats.J. Pharm. Sci. 64:112–114 (1975).

    Article  CAS  PubMed  Google Scholar 

  20. J. Glowinski and L. L. Iversen. Regional studies of catecholamines in the rat brain. I.J. Neurochem. 13:655–669 (1966).

    Article  CAS  PubMed  Google Scholar 

  21. G. Paalzow. The potential role of catecholamines in drug induced changes of central pain responses, with special emphasis on morphine effects in the rat.Acta Univ. Upsaliens. 9:1–45 (1976).

    Google Scholar 

  22. R. Hems, B. D. Ross, M. N. Berry, and H. A. Krebs. Gluconeogenesis in the perfused rat liver.Biochem. J. 101:284–292 (1966).

    CAS  PubMed Central  PubMed  Google Scholar 

  23. B. E. Dahlström, J. Jonsson, and L. K. Paalzow. Metabolism of morphine in the perfused rat liver.Acta Pharmacol. Toxicol. 39:46–52 (1976).

    Article  Google Scholar 

  24. K. S. Pang and M. Rowland. Hepatic clearance of drugs. I. Theoretical considerations of a “well-stirred” model and a “parallel tube” model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance.J. Phamacokin. Biopharm. 5:625–653 (1977).

    Article  CAS  Google Scholar 

  25. W. J. Jusko and M. Gibaldi. Effects of change in elimination on various parameters of the two-compartment open model.J. Pharm. Sci. 61:1270–1273 (1972).

    Article  CAS  PubMed  Google Scholar 

  26. L. Paalzow and P. O. Edlund. Multiple receptor responses: A new concept to describe the relationship between pharmacological effects and pharmacokinetics of a drug. Studies on clonidine in the rat and cat.J. Pharmacokin. Biopharm. 7:495–510 (1979).

    Article  CAS  Google Scholar 

  27. G. Haeusler. Studies on the possible contribution of a peripheral presynaptic action of clonidine and dopamine to their vascular effects underin vivo conditions.Naunyn-Schmiedeberg's Arch. Pharmacol. 295:191–202 (1976).

    Article  CAS  Google Scholar 

  28. H. Ozawa, C.-S. Chen, H. Watanabe, and T. Uematsu. Effect of clonidine on blood pressure, heart rate and body temperature in conscious rats.Jpn. J. Pharmacol. 27:47–54 (1977).

    Article  CAS  PubMed  Google Scholar 

  29. M. Rowland, L. Z. Benet, and G. G. Graham. Clearance concepts in pharmacokinetics.J. Pharmacokin. Biopharm. 1:123–136 (1973).

    Article  CAS  Google Scholar 

  30. G. R. Wilkinson. Pharmacokinetics of drug disposition hemodynamic considerations.Ann. Rev. Pharmacol. 15:11–27 (1975).

    Article  CAS  PubMed  Google Scholar 

  31. J. G. Wagner.Fundamentals of Clinical Pharmacokinetics, Drug Intelligence Publications, Hamilton, Ill, 1975, pp. 82–85.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pharmacology, Central Research and Control Laboratory of the National Corporation of Swedish Pharmacies, S-171 03, Solna, Sweden

    L. K. Paalzow & P. O. Edlund

  2. Faculty of Pharmacy, University of Uppsala, Biomedical Center, S-751 23, Uppsala, Sweden

    L. K. Paalzow

Authors
  1. L. K. Paalzow
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P. O. Edlund
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Paalzow, L.K., Edlund, P.O. Pharmacokinetics of clonidine in the rat and cat. Journal of Pharmacokinetics and Biopharmaceutics 7, 481–494 (1979). https://doi.org/10.1007/BF01062390

Download citation

  • Received:

  • Revised:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01062390

Key words

Search

Navigation